0001140361-19-018086.txt : 20191007 0001140361-19-018086.hdr.sgml : 20191007 20191007193313 ACCESSION NUMBER: 0001140361-19-018086 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191007 FILED AS OF DATE: 20191007 DATE AS OF CHANGE: 20191007 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Seizinger Bernd R. CENTRAL INDEX KEY: 0001789042 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39069 FILM NUMBER: 191141682 MAIL ADDRESS: STREET 1: 535 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 FORMER NAME: FORMER CONFORMED NAME: Seizinger Bernd DATE OF NAME CHANGE: 20190923 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aprea Therapeutics, Inc. CENTRAL INDEX KEY: 0001781983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 535 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6095104718 MAIL ADDRESS: STREET 1: 535 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 4 1 form4.xml FORM 4 X0306 4 2019-10-07 0001781983 Aprea Therapeutics, Inc. APRE 0001789042 Seizinger Bernd R. 535 BOYLSTON STREET BOSTON MA 02116 true Common Stock 2019-10-07 4 M 0 263970 0.07 A 263970 D Stock Option (right to buy) 0.07 2019-10-07 4 M 0 263970 0 D 2025-09-04 Common Stock 263970 0 D These options vested in connection with the completion of the Issuer's initial public offering. /s/ Scott M. Coiante, attorney-in-fact 2019-10-07